UKHSA reaches vaccine deal with CSL Seqirus
Pharma Times
SEPTEMBER 26, 2023
Agreement will provide timely boost to pandemic preparedness against influenza - News - PharmaTimes
news influenza 
Momentum for Poolbeg and CytoReason’s AI collaboration
Pharma Times
JUNE 29, 2023
Partnership establishes several influenza therapy targets using artificial intelligence - News - PharmaTimes
116 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sciensano coordinates a national workshop on the “one health surveillance” of zoonotic influenza viruses and salmonella
Sciensano
OCTOBER 10, 2023
Sciensano organised a workshop on September 29, 2023 on the surveillance of zoonotic influenza viruses and salmonella in Belgium. Zoonotic influenza viruses and salmonella are two good examples of this link, which demonstrate that cooperation between the public health sector and the food and veterinary sector is crucial. “
Scientist 64
64 Scientist 64
64 
This week in drug discovery (26-30 June)
Drug Discovery World
JUNE 30, 2023
News round-up for 26-30 June by DDW Digital Content Editor Diana Spencer. This week we have heard about a number of studies that demonstrate an inventive solution to an old problem, either through the use of an original approach or new, advanced technology. The top stories: Could a monoclonal antibody treat peanut allergy?
Allergies 52
52 
Laws Promoting Flu Shot for Hospital Workers Can Cut Deaths
The Pharma Data
JANUARY 8, 2021
8, 2021 — State laws promoting hospital worker vaccination against influenza may be effective for reducing monthly pneumonia and influenza mortality rates, especially among the elderly, according to a study published online Jan. The effects were largest among elderly persons and during peak influenza months. Professional.
Vaccination 52
52 
This week in drug discovery (15-19 May)
Drug Discovery World
MAY 19, 2023
News round-up for 15-19 May by DDW Digital Content Editor Diana Spencer. This week we have reported on the launch of a number of new Phase I trials in a range of disease areas.
This week in drug discovery (4-8 March)
Drug Discovery World
MARCH 8, 2024
News round-up for 4-8 March by DDW Digital Content Editor Diana Spencer.
Antibody 52
52 
This week in drug discovery (19-23 September)
Drug Discovery World
SEPTEMBER 23, 2022
News round-up for 19-23 September by DDW Editor Reece Armstrong. The last week has seen data emerge on how Omicron infection could protect against influenza, how breast cancer cells evade therapies, and two approvals on rare diseases in the US and EU. This week’s top stories: . Omicron infection likely to protect against flu.
Drugs 52
52 
Influenza Vaccination May Have Protective Effect on COVID-19
The Pharma Data
NOVEMBER 3, 2020
Influenza Vaccination May Have Protective Effect on COVID-19. 3, 2020 — Influenza vaccination may have a protective effect for COVID-19 -positive patients, according to a brief report recently published in the Journal of the American Board of Family Medicine. Influenza vaccination status and comorbidities were examined.
Vaccination 52
52 
Either Trivalent Flu Vaccine Safe for Use in Seniors
The Pharma Data
JANUARY 20, 2021
20, 2021 — Either the trivalent adjuvanted inactivated influenza vaccine (aIIV3) or the trivalent high-dose inactivated influenza vaccine (HD-IIV3) is safe to use in older adults, according to a study published online Jan. More News Resources. Professional. Either Trivalent Flu Vaccine Safe for Use in Seniors.
Vaccination 52
52 
This week in drug discovery (6-10 March)
Drug Discovery World
MARCH 10, 2023
News round-up for 6-10 March by DDW Digital Content Editor Diana Spencer. New results for severe influenza and inflammatory conditions Poolbeg Pharma has announced data from the bacterial lipopolysaccharide (‘LPS’) human challenge trial for POLB 001, a viral strain agnostic, small molecule immunomodulator.
In-Vivo 52
52 
About One in Five Children Have Vaccine-Hesitant Parent
The Pharma Data
NOVEMBER 9, 2020
Influenza vaccination coverage was 26 percent lower for children of parents reporting being hesitant about childhood shots compared with parents not reporting hesitancy. More News Resources. Professional. About One in Five Children Have Vaccine-Hesitant Parent. MONDAY, Nov. 9 in Pediatrics. Santibanez, Ph.D., from the U.S.
Vaccination 52
52 
Are Scientists Close to a ‘Universal’ Flu Vaccine?
The Pharma Data
DECEMBER 7, 2020
The vaccine produces antibodies that target the part of the surface protein of the influenza virus known to neutralize different influenza strains, the researchers said. In addition, revaccinating individuals annually is a huge and expensive undertaking,” Krammer added in a Mount Sinai news release.
Scientist 52
52 
Proactive Interventions Cut Spending for Children With Asthma
The Pharma Data
OCTOBER 21, 2020
Melike Yildirim, from the Georgia Institute of Technology in Atlanta, and colleagues used patient data from Medicaid Analytic eXtract files to identify patients with persistent asthma in 2010 and 2011 from New York and Michigan. Influenza vaccination was associated with a decreased probability of primary care physician visits (6 to 3.5
Vaccination 52
52 
CDC: Vaccination Coverage Generally High by Age 24 Months
The Pharma Data
OCTOBER 23, 2020
Coverage with at least two doses of influenza vaccine was higher for children born during 2016 to 2017 versus 2014 to 2015 (58.1 More News Resources. Professional. CDC: Vaccination Coverage Generally High by Age 24 Months. FRIDAY, Oct. 23 issue of the U.S. 90 percent, although in 14 states MMR coverage was <90 percent.
Vaccination 52
52 
Top stories: Covid-19
Drug Discovery World
OCTOBER 4, 2022
An update on the latest Covid-19 news by DDW Digital Content Editor Diana Spencer . We found out that Omicron infection protects against flu, studies in potential treatments for severe Covid have shown promise, and new genetic insights into ME and CSF were revealed that could have implications in long Covid. . The top stories: .
Has Social Distancing Done More Than Just Flatten the Curve?
XTalks
AUGUST 19, 2020
Additionally, weekly influenza numbers and respiratory syncytial virus (RSV) infections in children were recorded, nationwide, and were compared to numbers from 2015. Additionally, the influenza season was shorter and the weekly rate of new cases decreased faster compared with the previous four influenza seasons.
Genetic Disease 111
111 
COVID-19 Is Far More Lethal, Damaging Than Flu, Data Shows
The Pharma Data
DECEMBER 18, 2020
17 in The Lancet Respiratory Medicine journal, arrived at similar conclusions: Nearly twice as many people were admitted to the hospital for COVID-19 at the height of the pandemic than were for influenza at the peak of the 2018/2019 flu season. “We know so little about COVID-19 because of its newness,” Al-Aly noted.
Insulin 52
52 
American Indians/Alaska Natives Have Elevated COVID-19 Mortality
The Pharma Data
DECEMBER 10, 2020
from the Council of State and Territorial Epidemiologists in Atlanta, and colleagues examined the prevalence of COVID-19 deaths in the AI/AN population in light of disproportionate mortality experienced during the 2009 influenza A(H1N1) pandemic. More News Resources. Professional. THURSDAY, Dec. 11 issue of the U.S. © 2020 HealthDay.
Research 52
52 Research 52
52 
XBB.1.5 Omicron Subvariant Being Closely Watched as Most Transmissible Variant Yet
XTalks
JANUARY 11, 2023
It is the most transmissible variant that has been detected yet,” Maria Van Kerkhove, the COVID-19 technical lead at the World Health Organization (WHO), said during a news conference last week. The new subvariant has also been dubbed “Kraken” by some scientists. While the XBB.1.5 Nonetheless, it has been found in 29 countries so far.
Scientist 98
98 
AHA: Young Adults With CVD Have Low Flu Vaccination Rates
The Pharma Data
NOVEMBER 10, 2020
10, 2020 — Many young adults with cardiovascular disease (CVD) do not receive influenza vaccination, according to a study presented at the American Heart Association Scientific Sessions 2020, held virtually from Nov. More News Resources. Professional. AHA: Young Adults With CVD Have Low Flu Vaccination Rates. TUESDAY, Nov.
Vaccination 52
52 
Pfizer/BioNTech say COVID-19 vaccine works against UK variant
pharmaphorum
JANUARY 20, 2021
Unlike for influenza vaccines, the reduction in neutralisation that might indicate the need for a strain change has not been established for COVID-19 vaccines,” it goes on.
Vaccination 98
98 
Keeping tabs on Covid-19: FDA authorizes restart of AstraZeneca clinical trial and Novavax expands its Maryland manufacturing sites
The Pharma Data
NOVEMBER 8, 2020
Pascal Soriot, CEO of AstraZeneca, said: “The restart of clinical trials across the world is great news as it allows us to continue our efforts to develop this vaccine to help defeat this terrible pandemic. The recommendations from these reviews were supported by international regulators.
IL-6 drugs do work in COVID-19, says UK, as it plans NHS use
pharmaphorum
JANUARY 8, 2021
REMAP-CAP has been running since 2016, with the aim of putting dozens of drugs through their paces to see if they can improve the prospects of people with severe community-acquired pneumonia (CAP) caused by influenza, but was expanded to include COVID-19 patients after the pandemic took hold.
Drugs 99
99 
Researchers Discover Genetic Errors and Rogue Antibodies in Cases of Severe COVID-19 Infection
XTalks
SEPTEMBER 30, 2020
In collaboration with clinicians around the world, Casanova’s team studied the genomes of COVID-19 patients, focusing on a set of 13 genes involved in interferon immunity against influenza. Autoimmune Attack and COVID-19 Symptom Severity.
Antibody 135
135 
The invisible burden of RSV on older adults
pharmaphorum
DECEMBER 15, 2022
Despite the renewed public focus on RSV seen in the news recently, there is still a great deal of work to be done to uncover realities of RSV in the UK, especially among older populations. Weekly national Influenza and COVID-19 surveillance report. References. UK Health Security Agency. Week 47 report (up to week 46 data).
Scientist 67
67 
High Blood Levels of Cadmium May Be Tied to Worse COVID-19
The Pharma Data
DECEMBER 16, 2020
After adjusting for a number of factors, the investigators found that patients with cadmium levels in the 80th percentile were 15% more likely to die of influenza or pneumonia than those in the 20th percentile. Cadmium was measured in urine in the first survey and in blood in the second. “COVID-19 may not be a one-time event.
Keeping tabs on Covid-19: AstraZeneca ups nasal-spray vaccine production and air…
The Pharma Data
AUGUST 14, 2020
With the World Health Organization this week publishing a list of the latest Covid-19 candidate vaccines from around the world , Pharma IQ’s weekly round-up looks at developments from the past seven days including news on how the pharma industry plans to handle vaccine disruption and flu season.
Vaccination 52
52 
Moderna ramps up EU COVID jab capacity via Lonza deal
pharmaphorum
JUNE 2, 2021
Full approval means it could be used routinely in future as an annual booster, much like the seasonal influenza vaccine. Pfizer and BioNTech filed for FDA approval of their COVID-19 vaccine on 7 May. WHO backs Sinovac shot.
Vaccination 52
52 
What Challenges Is the Vaccine Industry Facing When Dealing with the Flu and COVID-19?
XTalks
OCTOBER 26, 2023
Fall marks the beginning of the “flu season,” the period during the year when influenza (flu) viruses are in increased circulation and cause illness at higher rates than usual. Influenza results in thousands of deaths in the US each year. This includes the emergence of new variants and vaccination strategies.
Vaccination 105
105 
The hidden danger of isolated congenital asplenia
pharmaphorum
MARCH 24, 2021
After about 40 minutes, the doctor came out and delivered the devastating news that they had been unable to restart his heart. “I Unbeknownst to Allison, her “rainbow child with the megawatt smile” had contracted haemophilus influenzae type A. Allison, who wasn’t allowed into the emergency room, could do nothing but wait. Team4Travis.
Doctors 98
98 
Lockdowns May Be Keeping Kids’ Asthma Attacks at Bay: Study
The Pharma Data
DECEMBER 4, 2020
David Fagan, vice chair of Pediatric Administration-Ambulatory General Pediatrics at Cohen Children’s Medical Center in New Hyde Park, N.Y. “Given the lockdown, with schools closing and families staying home, we witnessed a sudden steep decline in cases of [non-COVID] viral illnesses such as influenza,” Fagan said.
Allergies 52
52 
Biopharma Update on the Novel Coronavirus: October 20
The Pharma Data
OCTOBER 19, 2020
News information is not all-inclusive and updates are published once a week on Tuesdays. . . New Guidance: The FDA issued and implemented new guidance, Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. FDA Actions.
Vaccination 52
52 
For Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID Shot
The Pharma Data
JANUARY 22, 2021
The studies in this review looked at the effects of psychological factors and behaviors on immune response to a range of vaccines, including for influenza, hepatitis B, typhoid and pneumonia. This evidence is likely relevant to the COVID-19 vaccine, the researchers said. Having some side effects is a normal response to vaccines.
The hidden danger of isolated congenital asplenia
pharmaphorum
MARCH 24, 2021
After about 40 minutes, the doctor came out and delivered the devastating news that they had been unable to restart his heart. “I Unbeknownst to Allison, her “rainbow child with the megawatt smile” had contracted haemophilus influenzae type A. Allison, who wasn’t allowed into the emergency room, could do nothing but wait. Team4Travis.
Doctors 57
57 
Top tweets: CDC’s concern over UK’s Monkeypox outbreak and more
Pharmaceutical Technology
JULY 1, 2022
Ian M Mackay, a scientist and an adjunct associate professor at the University of Queensland, shared an article on the five-year exponential rise in laboratory-confirmed influenza cases in Australia. The most popular tweets on infectious diseases in May 2022: Top five. Helen Branswell’s tweet on CDC’s concern over UK’s Monkeypox outbreak.
Vaccination 130
130 
Asia-Pacific Roundup: New Zealand bans unapproved COVID vaccines
The Pharma Data
MAY 4, 2021
TGA fined Global Therapeutics’ for its alleged use of “unapproved references to ‘serious’ conditions such as upper respiratory tract infections, bronchitis, influenza, and viral and bacterial infections.” Other news. The company allegedly advertised medicines for indications other than those accepted in the ARTG. .
Vaccination 52
52 
Novel antibodies target ‘dark side’ of influenza virus protein
Drug Discovery World
MARCH 5, 2024
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored ‘dark side’ of the neuraminidase (NA) protein head.
Antibody 59
59 
AI-led programme identifies multiple influenza drug targets
Drug Discovery World
JUNE 29, 2023
Poolbeg Pharma, a clinical-stage biopharmaceutical company focusing on infectious and other prevalent diseases with a high unmet medical need, has announced a breakthrough in its influenza AI Programme with CytoReason. Poolbeg has been working with CytoReason since March 2022.
Drugs 98
98 
Xofluza Approved for Postexposure Prevention of Flu
The Pharma Data
NOVEMBER 24, 2020
24, 2020 — The approved indication for Xofluza (baloxavir marboxil) has been expanded to include postexposure prevention of influenza for those who may have come in contact with someone who has the flu, the U.S. These data were published in the New England Journal of Medicine in July. More News Resources. Professional.
Drugs 52
52 
Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine
The Pharma Data
APRIL 1, 2021
Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine. Sanofi announces investment of more than €600 million to build a new vaccine facility in Toronto to increase supply of its differentiated influenza vaccines in Canada, the United States and Europe.
Vaccination 52
52 
mRNA can deliver universal flu vaccine, say US researchers
pharmaphorum
NOVEMBER 25, 2022
Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of influenza that could form the basis of a future universal jab. That included viruses that were significantly different from those included in the shot.
Vaccination 104
104 
FluMist Nasal Flu Vaccine Gets FDA Consideration for Self-Administration
XTalks
OCTOBER 25, 2023
The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. In the US, it is estimated that on average, eight percent of the population gets sick each season from the influenza virus that causes.
Vaccination 59
59 
New DDW Highlights podcast: 22 January 2024
Drug Discovery World
JANUARY 22, 2024
With seasonal illnesses running amok in the western hemisphere at the moment, it is perhaps not surprising that this week’s news highlights focus on viruses and immunity. The post New DDW Highlights podcast: 22 January 2024 appeared first on Drug Discovery World (DDW).
Drugs 52
52 
Let's personalize your content